[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

High-density Multiplexed Diagnostic Assays Market - Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: HBE5032968ACEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of High-density Multiplexed Diagnostic Assays in Global, including the following market information:

Global High-density Multiplexed Diagnostic Assays Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global High-density Multiplexed Diagnostic Assays market was valued at 1432.8 million in 2021 and is projected to reach US$ 3179 million by 2028, at a CAGR of 12.1% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

High-density Multiplexed Diagnostic Assays Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of High-density Multiplexed Diagnostic Assays include Abbott, Hologic, Thermo Fisher Scientific, Luminex, Randox Laboratories, Gold Standard Diagnostics, F. Hoffmann-La Roche, Agilent Technologies and Bio-Rad Laboratories and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the High-density Multiplexed Diagnostic Assays companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global High-density Multiplexed Diagnostic Assays Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global High-density Multiplexed Diagnostic Assays Market Segment Percentages, by Type, 2021 (%)
  • High-density Multiplexed Diagnostic Assays
  • Very High-density Multiplexed Diagnostic Assays
Global High-density Multiplexed Diagnostic Assays Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global High-density Multiplexed Diagnostic Assays Market Segment Percentages, by Application, 2021 (%)
  • Hospitals
  • Academic Research Institutes
  • Others
Global High-density Multiplexed Diagnostic Assays Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global High-density Multiplexed Diagnostic Assays Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies High-density Multiplexed Diagnostic Assays revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies High-density Multiplexed Diagnostic Assays revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Abbott
  • Hologic
  • Thermo Fisher Scientific
  • Luminex
  • Randox Laboratories
  • Gold Standard Diagnostics
  • F. Hoffmann-La Roche
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Erba Diagnostics
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 High-density Multiplexed Diagnostic Assays Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global High-density Multiplexed Diagnostic Assays Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HIGH-DENSITY MULTIPLEXED DIAGNOSTIC ASSAYS OVERALL MARKET SIZE

2.1 Global High-density Multiplexed Diagnostic Assays Market Size: 2021 VS 2028
2.2 Global High-density Multiplexed Diagnostic Assays Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top High-density Multiplexed Diagnostic Assays Players in Global Market
3.2 Top Global High-density Multiplexed Diagnostic Assays Companies Ranked by Revenue
3.3 Global High-density Multiplexed Diagnostic Assays Revenue by Companies
3.4 Top 3 and Top 5 High-density Multiplexed Diagnostic Assays Companies in Global Market, by Revenue in 2021
3.5 Global Companies High-density Multiplexed Diagnostic Assays Product Type
3.6 Tier 1, Tier 2 and Tier 3 High-density Multiplexed Diagnostic Assays Players in Global Market
  3.6.1 List of Global Tier 1 High-density Multiplexed Diagnostic Assays Companies
  3.6.2 List of Global Tier 2 and Tier 3 High-density Multiplexed Diagnostic Assays Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global High-density Multiplexed Diagnostic Assays Market Size Markets, 2021 & 2028
  4.1.2 High-density Multiplexed Diagnostic Assays
  4.1.3 Very High-density Multiplexed Diagnostic Assays
4.2 By Type - Global High-density Multiplexed Diagnostic Assays Revenue & Forecasts
  4.2.1 By Type - Global High-density Multiplexed Diagnostic Assays Revenue, 2017-2022
  4.2.2 By Type - Global High-density Multiplexed Diagnostic Assays Revenue, 2023-2028
  4.2.3 By Type - Global High-density Multiplexed Diagnostic Assays Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global High-density Multiplexed Diagnostic Assays Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Academic Research Institutes
  5.1.4 Others
5.2 By Application - Global High-density Multiplexed Diagnostic Assays Revenue & Forecasts
  5.2.1 By Application - Global High-density Multiplexed Diagnostic Assays Revenue, 2017-2022
  5.2.2 By Application - Global High-density Multiplexed Diagnostic Assays Revenue, 2023-2028
  5.2.3 By Application - Global High-density Multiplexed Diagnostic Assays Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global High-density Multiplexed Diagnostic Assays Market Size, 2021 & 2028
6.2 By Region - Global High-density Multiplexed Diagnostic Assays Revenue & Forecasts
  6.2.1 By Region - Global High-density Multiplexed Diagnostic Assays Revenue, 2017-2022
  6.2.2 By Region - Global High-density Multiplexed Diagnostic Assays Revenue, 2023-2028
  6.2.3 By Region - Global High-density Multiplexed Diagnostic Assays Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America High-density Multiplexed Diagnostic Assays Revenue, 2017-2028
  6.3.2 US High-density Multiplexed Diagnostic Assays Market Size, 2017-2028
  6.3.3 Canada High-density Multiplexed Diagnostic Assays Market Size, 2017-2028
  6.3.4 Mexico High-density Multiplexed Diagnostic Assays Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe High-density Multiplexed Diagnostic Assays Revenue, 2017-2028
  6.4.2 Germany High-density Multiplexed Diagnostic Assays Market Size, 2017-2028
  6.4.3 France High-density Multiplexed Diagnostic Assays Market Size, 2017-2028
  6.4.4 U.K. High-density Multiplexed Diagnostic Assays Market Size, 2017-2028
  6.4.5 Italy High-density Multiplexed Diagnostic Assays Market Size, 2017-2028
  6.4.6 Russia High-density Multiplexed Diagnostic Assays Market Size, 2017-2028
  6.4.7 Nordic Countries High-density Multiplexed Diagnostic Assays Market Size, 2017-2028
  6.4.8 Benelux High-density Multiplexed Diagnostic Assays Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia High-density Multiplexed Diagnostic Assays Revenue, 2017-2028
  6.5.2 China High-density Multiplexed Diagnostic Assays Market Size, 2017-2028
  6.5.3 Japan High-density Multiplexed Diagnostic Assays Market Size, 2017-2028
  6.5.4 South Korea High-density Multiplexed Diagnostic Assays Market Size, 2017-2028
  6.5.5 Southeast Asia High-density Multiplexed Diagnostic Assays Market Size, 2017-2028
  6.5.6 India High-density Multiplexed Diagnostic Assays Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America High-density Multiplexed Diagnostic Assays Revenue, 2017-2028
  6.6.2 Brazil High-density Multiplexed Diagnostic Assays Market Size, 2017-2028
  6.6.3 Argentina High-density Multiplexed Diagnostic Assays Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa High-density Multiplexed Diagnostic Assays Revenue, 2017-2028
  6.7.2 Turkey High-density Multiplexed Diagnostic Assays Market Size, 2017-2028
  6.7.3 Israel High-density Multiplexed Diagnostic Assays Market Size, 2017-2028
  6.7.4 Saudi Arabia High-density Multiplexed Diagnostic Assays Market Size, 2017-2028
  6.7.5 UAE High-density Multiplexed Diagnostic Assays Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott
  7.1.1 Abbott Corporate Summary
  7.1.2 Abbott Business Overview
  7.1.3 Abbott High-density Multiplexed Diagnostic Assays Major Product Offerings
  7.1.4 Abbott High-density Multiplexed Diagnostic Assays Revenue in Global Market (2017-2022)
  7.1.5 Abbott Key News
7.2 Hologic
  7.2.1 Hologic Corporate Summary
  7.2.2 Hologic Business Overview
  7.2.3 Hologic High-density Multiplexed Diagnostic Assays Major Product Offerings
  7.2.4 Hologic High-density Multiplexed Diagnostic Assays Revenue in Global Market (2017-2022)
  7.2.5 Hologic Key News
7.3 Thermo Fisher Scientific
  7.3.1 Thermo Fisher Scientific Corporate Summary
  7.3.2 Thermo Fisher Scientific Business Overview
  7.3.3 Thermo Fisher Scientific High-density Multiplexed Diagnostic Assays Major Product Offerings
  7.3.4 Thermo Fisher Scientific High-density Multiplexed Diagnostic Assays Revenue in Global Market (2017-2022)
  7.3.5 Thermo Fisher Scientific Key News
7.4 Luminex
  7.4.1 Luminex Corporate Summary
  7.4.2 Luminex Business Overview
  7.4.3 Luminex High-density Multiplexed Diagnostic Assays Major Product Offerings
  7.4.4 Luminex High-density Multiplexed Diagnostic Assays Revenue in Global Market (2017-2022)
  7.4.5 Luminex Key News
7.5 Randox Laboratories
  7.5.1 Randox Laboratories Corporate Summary
  7.5.2 Randox Laboratories Business Overview
  7.5.3 Randox Laboratories High-density Multiplexed Diagnostic Assays Major Product Offerings
  7.5.4 Randox Laboratories High-density Multiplexed Diagnostic Assays Revenue in Global Market (2017-2022)
  7.5.5 Randox Laboratories Key News
7.6 Gold Standard Diagnostics
  7.6.1 Gold Standard Diagnostics Corporate Summary
  7.6.2 Gold Standard Diagnostics Business Overview
  7.6.3 Gold Standard Diagnostics High-density Multiplexed Diagnostic Assays Major Product Offerings
  7.6.4 Gold Standard Diagnostics High-density Multiplexed Diagnostic Assays Revenue in Global Market (2017-2022)
  7.6.5 Gold Standard Diagnostics Key News
7.7 F. Hoffmann-La Roche
  7.7.1 F. Hoffmann-La Roche Corporate Summary
  7.7.2 F. Hoffmann-La Roche Business Overview
  7.7.3 F. Hoffmann-La Roche High-density Multiplexed Diagnostic Assays Major Product Offerings
  7.7.4 F. Hoffmann-La Roche High-density Multiplexed Diagnostic Assays Revenue in Global Market (2017-2022)
  7.7.5 F. Hoffmann-La Roche Key News
7.8 Agilent Technologies
  7.8.1 Agilent Technologies Corporate Summary
  7.8.2 Agilent Technologies Business Overview
  7.8.3 Agilent Technologies High-density Multiplexed Diagnostic Assays Major Product Offerings
  7.8.4 Agilent Technologies High-density Multiplexed Diagnostic Assays Revenue in Global Market (2017-2022)
  7.8.5 Agilent Technologies Key News
7.9 Bio-Rad Laboratories
  7.9.1 Bio-Rad Laboratories Corporate Summary
  7.9.2 Bio-Rad Laboratories Business Overview
  7.9.3 Bio-Rad Laboratories High-density Multiplexed Diagnostic Assays Major Product Offerings
  7.9.4 Bio-Rad Laboratories High-density Multiplexed Diagnostic Assays Revenue in Global Market (2017-2022)
  7.9.5 Bio-Rad Laboratories Key News
7.10 Erba Diagnostics
  7.10.1 Erba Diagnostics Corporate Summary
  7.10.2 Erba Diagnostics Business Overview
  7.10.3 Erba Diagnostics High-density Multiplexed Diagnostic Assays Major Product Offerings
  7.10.4 Erba Diagnostics High-density Multiplexed Diagnostic Assays Revenue in Global Market (2017-2022)
  7.10.5 Erba Diagnostics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES

Table 1. High-density Multiplexed Diagnostic Assays Market Opportunities & Trends in Global Market
Table 2. High-density Multiplexed Diagnostic Assays Market Drivers in Global Market
Table 3. High-density Multiplexed Diagnostic Assays Market Restraints in Global Market
Table 4. Key Players of High-density Multiplexed Diagnostic Assays in Global Market
Table 5. Top High-density Multiplexed Diagnostic Assays Players in Global Market, Ranking by Revenue (2021)
Table 6. Global High-density Multiplexed Diagnostic Assays Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global High-density Multiplexed Diagnostic Assays Revenue Share by Companies, 2017-2022
Table 8. Global Companies High-density Multiplexed Diagnostic Assays Product Type
Table 9. List of Global Tier 1 High-density Multiplexed Diagnostic Assays Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 High-density Multiplexed Diagnostic Assays Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - High-density Multiplexed Diagnostic Assays Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - High-density Multiplexed Diagnostic Assays Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - High-density Multiplexed Diagnostic Assays Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - High-density Multiplexed Diagnostic Assays Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global High-density Multiplexed Diagnostic Assays Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global High-density Multiplexed Diagnostic Assays Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Corporate Summary
Table 31. Abbott High-density Multiplexed Diagnostic Assays Product Offerings
Table 32. Abbott High-density Multiplexed Diagnostic Assays Revenue (US$, Mn), (2017-2022)
Table 33. Hologic Corporate Summary
Table 34. Hologic High-density Multiplexed Diagnostic Assays Product Offerings
Table 35. Hologic High-density Multiplexed Diagnostic Assays Revenue (US$, Mn), (2017-2022)
Table 36. Thermo Fisher Scientific Corporate Summary
Table 37. Thermo Fisher Scientific High-density Multiplexed Diagnostic Assays Product Offerings
Table 38. Thermo Fisher Scientific High-density Multiplexed Diagnostic Assays Revenue (US$, Mn), (2017-2022)
Table 39. Luminex Corporate Summary
Table 40. Luminex High-density Multiplexed Diagnostic Assays Product Offerings
Table 41. Luminex High-density Multiplexed Diagnostic Assays Revenue (US$, Mn), (2017-2022)
Table 42. Randox Laboratories Corporate Summary
Table 43. Randox Laboratories High-density Multiplexed Diagnostic Assays Product Offerings
Table 44. Randox Laboratories High-density Multiplexed Diagnostic Assays Revenue (US$, Mn), (2017-2022)
Table 45. Gold Standard Diagnostics Corporate Summary
Table 46. Gold Standard Diagnostics High-density Multiplexed Diagnostic Assays Product Offerings
Table 47. Gold Standard Diagnostics High-density Multiplexed Diagnostic Assays Revenue (US$, Mn), (2017-2022)
Table 48. F. Hoffmann-La Roche Corporate Summary
Table 49. F. Hoffmann-La Roche High-density Multiplexed Diagnostic Assays Product Offerings
Table 50. F. Hoffmann-La Roche High-density Multiplexed Diagnostic Assays Revenue (US$, Mn), (2017-2022)
Table 51. Agilent Technologies Corporate Summary
Table 52. Agilent Technologies High-density Multiplexed Diagnostic Assays Product Offerings
Table 53. Agilent Technologies High-density Multiplexed Diagnostic Assays Revenue (US$, Mn), (2017-2022)
Table 54. Bio-Rad Laboratories Corporate Summary
Table 55. Bio-Rad Laboratories High-density Multiplexed Diagnostic Assays Product Offerings
Table 56. Bio-Rad Laboratories High-density Multiplexed Diagnostic Assays Revenue (US$, Mn), (2017-2022)
Table 57. Erba Diagnostics Corporate Summary
Table 58. Erba Diagnostics High-density Multiplexed Diagnostic Assays Product Offerings
Table 59. Erba Diagnostics High-density Multiplexed Diagnostic Assays Revenue (US$, Mn), (2017-2022)

LIST OF FIGURES

Figure 1. High-density Multiplexed Diagnostic Assays Segment by Type in 2021
Figure 2. High-density Multiplexed Diagnostic Assays Segment by Application in 2021
Figure 3. Global High-density Multiplexed Diagnostic Assays Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global High-density Multiplexed Diagnostic Assays Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global High-density Multiplexed Diagnostic Assays Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by High-density Multiplexed Diagnostic Assays Revenue in 2021
Figure 8. By Type - Global High-density Multiplexed Diagnostic Assays Revenue Market Share, 2017-2028
Figure 9. By Application - Global High-density Multiplexed Diagnostic Assays Revenue Market Share, 2017-2028
Figure 10. By Region - Global High-density Multiplexed Diagnostic Assays Revenue Market Share, 2017-2028
Figure 11. By Country - North America High-density Multiplexed Diagnostic Assays Revenue Market Share, 2017-2028
Figure 12. US High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2017-2028
Figure 13. Canada High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe High-density Multiplexed Diagnostic Assays Revenue Market Share, 2017-2028
Figure 16. Germany High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2017-2028
Figure 17. France High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2017-2028
Figure 19. Italy High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2017-2028
Figure 20. Russia High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia High-density Multiplexed Diagnostic Assays Revenue Market Share, 2017-2028
Figure 24. China High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2017-2028
Figure 25. Japan High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2017-2028
Figure 28. India High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America High-density Multiplexed Diagnostic Assays Revenue Market Share, 2017-2028
Figure 30. Brazil High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa High-density Multiplexed Diagnostic Assays Revenue Market Share, 2017-2028
Figure 33. Turkey High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2017-2028
Figure 34. Israel High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2017-2028
Figure 36. UAE High-density Multiplexed Diagnostic Assays Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott High-density Multiplexed Diagnostic Assays Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Hologic High-density Multiplexed Diagnostic Assays Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Thermo Fisher Scientific High-density Multiplexed Diagnostic Assays Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Luminex High-density Multiplexed Diagnostic Assays Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Randox Laboratories High-density Multiplexed Diagnostic Assays Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Gold Standard Diagnostics High-density Multiplexed Diagnostic Assays Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. F. Hoffmann-La Roche High-density Multiplexed Diagnostic Assays Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Agilent Technologies High-density Multiplexed Diagnostic Assays Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bio-Rad Laboratories High-density Multiplexed Diagnostic Assays Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Erba Diagnostics High-density Multiplexed Diagnostic Assays Revenue Year Over Year Growth (US$, Mn) & (2017-2022)



More Publications